We are pleased to announce our first in-person course on Cardiometabolic Syndrome, Diabetes, and Obesity that will take place from 4–6 December 2025 at the European Heart House (EHH).

This course addresses a growing need in preventive cardiology: managing complex metabolic comorbidities such as type 2 diabetes, obesity, chronic kidney and liver disease, which significantly increase the risk of atherosclerotic cardiovascular disease (ASCVD).